This analysis only includes imaging interpretation, while sometimes tumor board decisions may depend on other factors including tumor genetics (such as IDH, MGMT, and 1p19q status), radiation treatment plans, or patient functional status [5,6,7,29], which were not fully explored within this analysis. This evidence concerns the gene MGMT and neoplasm.